EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cyanobacteria-Derived Extracellular Vesicles: A Novel Frontier in Drug Delivery and Therapeutics

Khalid A Asseri iD, Krishnaraju Venkatesan iD, Yahya I Asiri iD, Saud Alqahtani iD, Taha Alqahtani iD, Pooja Muralidharan, Shaimaa Elsayed Ramadan Genena, Durgaramani Sivadasan, Premalatha Paulsamy iD, Kumarappan Chidambaram iD

International Journal of Molecular Sciences · 19.12.2025 · 27 (1) · 4

DOI: 10.3390/ijms27010004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.12.2025. Verfasst von Khalid A Asseri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia. Hauptthemen laut MEDLINE: Cyanobacteria, Extracellular Vesicles, Drug Delivery Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Deanship of Scientific Research at King Khalid University, Deanship of Scientific Research at King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyanobacteria, known for their diverse and potent bioactive compounds, present a unique method for drug delivery via their extracellular vesicles (EVs), often described as exosome-like due to size and function but distinct in biogenesis. These naturally occurring vesicles, particularly those from cyanobacteria, are gaining attention as potential carriers for targeted drug delivery because of their biocompatibility, stability, and ability to encapsulate various bioactive compounds. However, cyanobacterial EVs remain underexplored as a dedicated nanocarrier platform, and their specific advantages and limitations relative to existing systems have not been systematically synthesized. This review explores the potential therapeutic uses of cyanobacterial EVs, emphasizing their roles in cancer treatment, antimicrobial therapies, neuroprotection, and immune modulation. We explore their biogenesis and structural features, comparing them to synthetic nanocarriers like polymeric nanoparticles and liposomes. The review also addresses the challenges of isolating and characterizing cyanobacterial EVs at scale and highlights the need for advancements in synthetic biology and genetic engineering to optimize their therapeutic potential. Despite these challenges, cyanobacterial EVs’ unique properties offer significant promise for advancing drug delivery systems and providing innovative solutions for treating complex diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyanobacteriaExtracellular VesiclesDrug Delivery SystemsHumansAnimalsDrug CarriersNanoparticles

Stichwörter der Autor:innen

bioactive compoundscyanobacterial EVsdrug delivery systemsnanocarrierstargeted therapeutics

Substanzen

Drug Carriers

Autor:innen und Institutionen

  • Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
  • Undergraduate Program, PSG College of Pharmacy, Peelamedu, Coimbatore 641004, India.
  • Clinical Biochemistry Department, University of Tabuk, Tabuk 41477, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, Jazan University, Jizan 45142, Saudi Arabia.
  • College of Nursing, Mahalah Branch for Girls, King Khalid University, Khamis Mushayt 61421, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.

ORCID-Profile: Khalid A Asseri, Krishnaraju Venkatesan, Yahya I Asiri, Saud Alqahtani, Taha Alqahtani, Premalatha Paulsamy, Kumarappan Chidambaram

Förderung

  • the Deanship of Scientific Research at King Khalid University
  • Deanship of Scientific Research at King Khalid University

Zitieren

APA

Asseri, K. A., Venkatesan, K., Asiri, Y. I., Alqahtani, S., Alqahtani, T., Muralidharan, P., Elsayed Ramadan Genena, S., Sivadasan, D., Paulsamy, P., & Chidambaram, K. (2025). Cyanobacteria-Derived Extracellular Vesicles: A Novel Frontier in Drug Delivery and Therapeutics. International Journal of Molecular Sciences, 27(1), 4. https://doi.org/10.3390/ijms27010004

Vancouver

Asseri KA, Venkatesan K, Asiri YI, Alqahtani S, Alqahtani T, Muralidharan P, et al. Cyanobacteria-Derived Extracellular Vesicles: A Novel Frontier in Drug Delivery and Therapeutics. International Journal of Molecular Sciences. 2025;27(1):4. doi:10.3390/ijms27010004

BibTeX
@article{Asseri2025,
  author = {Asseri, Khalid A and Venkatesan, Krishnaraju and Asiri, Yahya I and Alqahtani, Saud and Alqahtani, Taha and Muralidharan, Pooja and Elsayed Ramadan Genena, Shaimaa and Sivadasan, Durgaramani and Paulsamy, Premalatha and Chidambaram, Kumarappan},
  title = {Cyanobacteria-Derived Extracellular Vesicles: A Novel Frontier in Drug Delivery and Therapeutics},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {4},
  doi = {10.3390/ijms27010004}
}
Kostenlos starten →